← Signal Board

Cellbion financial statements

셀비온KRX:308430 · KOSDAQ
₩13,580-4.10%
2026-10-08 close

Cellbion's 2025 annual results accompany close-price data dated 2026-10-08. 2025 revenue was KRW 1.95B. 2025 operating profit was −KRW 8.24B.

Reported results

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 6.72
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
6.72
Beneish M-Score
—

Statistical flag unavailable

Sloan accrual
-7.23%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

1/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score1/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityDanger

매출 흑자인데 영업CF 적자 (OCF/매출 -209%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-311.7%
Interest coverage
-55x
Return on equity (ROE)
-24.6%

Operating margin −5pp

Operating loss
Interest coverageBase -55x adverse case -55.8x
Return on equity (ROE)Base -24.6% adverse case -25%

Revenue −15%

Interest coverage risk
Interest coverageBase -55x adverse case -46.7x
Return on equity (ROE)Base -24.6% adverse case -21%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -55x adverse case -31.5x
Return on equity (ROE)Base -24.6% adverse case -24.9%

Interest coverage limit

Already below the limit by 317.3pp

Interest coverage limit at an operating margin of 5.7%

Interest expense coverage threshold

Cellbion notifications

Quantus Signal · live data · not investment advice · Privacy Policy